Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis

Published:2012-10-27 Issue:22 Volume:104 Page:1712-1723
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Van de Velde Nicolas,Boily Marie-Claude,Drolet Mélanie,Franco Eduardo L.,Mayrand Marie-Hélène,Kliewer Erich V.,Coutlée François,Laprise Jean-François,Malagón Talía,Brisson Marc

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/104/22/1712/17311960/djs395.pdf

Reference73 articles.

1. Classification of papillomaviruses;de Villiers;Virology.,2004

2. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J Infect Dis.,2009

3. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis;Pou;Ann Otol Rhinol Laryngol.,1995

4. A review of human carcinogens—part B: biological agents;Bouvard;Lancet Oncol.,2009

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential impact of switching from a two- to one-dose gender-neutral routine HPV vaccination program in Canada: A mathematical modeling analysis;2024-05-29

2. Human Papillomavirus Co-circulation on a Partially Vaccinated Partnership Network;Studies in Computational Intelligence;2024

3. HPV Infection Profiles among People Living with HIV and HPV Vaccine Acceptance among Individuals with Different HIV Infection Statuses in China: A Systematic Meta-Analysis;Vaccines;2023-10-19

4. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis;BMC Medicine;2023-08-28

5. An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands;Infectious Diseases and Therapy;2023-08